The Panvascular Interplay in Pathophysiology and Prognosis of Cardiac Allograft Vasculopathy

J Am Coll Cardiol. 2022 Oct 25;80(17):1629-1632. doi: 10.1016/j.jacc.2022.08.753.

Authors

Mandeep R Mehra¹, Jacinthe Boulet², Matthieu Pelletier-Galarneau³

Affiliations

¹ Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mmehra@bwh.harvard.edu.
² Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Medical Imaging, Montreal Heart Institute, Montreal, Quebec, Canada.

PMID: 36265958
DOI: 10.1016/j.jacc.2022.08.753

No abstract available

Keywords: cardiac allograft vasculopathy; heart transplant; microvascular dysfunction; positron emission tomography; prognosis.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Allografts
Heart Diseases*
Heart Transplantation* / adverse effects
Humans
Prognosis